Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

Jan. 23, 1998

Gastrimmune significantly increases survival in advanced colorectal cancer

Jan. 22, 1998

Korean researchers characterize new antimicrobial/cytotoxic compound of microbial origin

Jan. 22, 1998

Targon and Duke University form oncology alliance

Jan. 22, 1998

European filing announced for Savedar (DepoCyt)

Jan. 21, 1998

Novel antitumor cyanoguanidines with good oral bioavailability

Jan. 21, 1998

Selective inhibitor of PDGF receptor autophosphorylation from Kirin Brewery

Jan. 21, 1998

Vertex describes new MDR-modulating and neuritogenic agents

Jan. 21, 1998

Genzyme Molecular Oncology, Schering-Plough collaborate to make gene therapy a reality

Jan. 21, 1998

Targeted cytotoxic LHRH analogues show potential as Rx for breast cancer

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...